Simplified cardiac damage staging improves prognostic stratification compared with the genereux classification in patients undergoing transcatheter aortic valve implantation
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Background Aortic stenosis is a disease where the prognosis is influenced by the degree of valve obstruction and by the extent of myocardial damage. In 2017 Généreux proposed a five-stage classification of extravalvular cardiac damage in severe AS, from isolated valvular disease to right-ventricular dysfunction. The One Hospital Clinical Service – SH TAVI Project, a multicenter registry including more than 10000 patients undergoing TAVI, provides an opportunity to examine the prognostic utility of cardiac-damage staging. Purpose This study aimed to: 1) Validate the Généreux classification in a large real-world TAVI cohort 2) Propose and test a simplified three-stage model that condenses the concept of cardiac damage. Methods All patients included underwent TAVI on or before May 31 2024, were screened and included those with baseline echocardiographic data sufficient for staging. Step 1: patients were categorized to the most advanced feature present, from Stage 4 backward to Stage 0. Stages were defined as follows: Stage 0: No cardiac damage Stage 1: Indexed LV mass >95 g/m² in women, >115 g/m² in men, E/e’>14, or LVEF34 mL/m²), AF or moderate/severe mitral regurgitation Stage 3: PAPs≥60 mmHg or moderate/severe tricuspid regurgitation Stage 4: Moderate/severe RV dysfunction (TAPSE
Fields of Study & Subjects
Cardiac Valve Diseases and Treatments
Aortic Disease and Treatment Approaches
Infective Endocarditis Diagnosis and Management
Publication details
- Journal / source
- European Heart Journal Supplements
- Volume
- 28
- Issue
- Supplement_3
- Publication date
- 1 March 2026
- Language
- EN